SCM
DMK

Sio Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Sio Capital Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,657
Closed -$10.1M – 68
2017
Q3 		$10.1M Buy
27,657
+25,907
+1,480% +$9.19M 5.25% 4
2017
Q2 		$637K Sell
1,750
-10,862
-86% -$3.25M 0.3% 53
2017
Q1 		$3.75M Sell
12,612
-2,403
-16% -$606K 2.1% 17
2016
Q4 		$3.31M Buy
15,015
+5,508
+58% +$1.1M 1.93% 21
2016
Q3 		$2.28M Sell
9,507
-271
-3% -$56.3K 1.57% 19
2016
Q2 		$1.92M Sell
9,778
-8,255
-46% -$3.81M 0.98% 30
2016
Q1 		$7.74M Sell
18,033
-805
-4% -$288K 2.83% 16
2015
Q4 		$7.12M Buy
18,838
+169
+0.9% +$53K 3.15% 10
2015
Q3 		$5.06M Buy
18,669
+1,208
+7% +$336K 3.47% 14
2015
Q2 		$5.13M Buy
17,461
+604
+4% +$182K 2.54% 11
2015
Q1 		$4.65M Buy
16,857
+163
+1% +$70.4K 2.65% 10
2014
Q4 		$7.21M Buy
+16,694
New +$5.3M 5.66% 5

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Sio Capital Management's DMK Position: Q4 2017 in Review

Sio Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2017, closing a stake of 27,657 shares — an estimated $10.1M sold.

Sio Capital Management first reported a position in DMK in Q4 2014 and held it in 12 quarters. The position peaked at $10.1M in Q3 2017. 58 funds tracked by Wall St. Rank hold DMK as of Q4 2017.

  • Sio Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2017 after selling out during the quarter.
  • Sio Capital Management sold 27,657 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2017, an estimated $10.1M.
  • Sio Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2014 and held it in 12 quarters.
  • Sio Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $10.1M in Q3 2017.
  • 58 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2017.

Based on Sio Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.